# Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100

- URL: https://theranews.net/blog/2026-03-17-psychedelicnewsbreaks-nrx-pharmaceuticals-inc-nasdaq-nrxp-receives-fda-guidance-70238e/
- Published: 2026-03-17
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: menafn
- Original report: https://menafn.com/1110867956/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Receives-FDA-Guidance-Supporting-NDA-Review-For-NRX-100
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> NRx Pharmaceuticals (NASDAQ: NRXP) announced that minutes from a Type C meeting with the U.S. Food and Drug Administration support the agency's willingness to ...

---
![Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100](/uploads/news-images/psychedelicnewsbreaks-nrx-pharmaceuticals-inc-n-20260317110048.jpeg)

---
*Originally reported by menafn. [Read more](https://menafn.com/1110867956/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Receives-FDA-Guidance-Supporting-NDA-Review-For-NRX-100)*

---

*Source: [https://menafn.com/1110867956/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Receives-FDA-Guidance-Supporting-NDA-Review-For-NRX-100](https://menafn.com/1110867956/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Receives-FDA-Guidance-Supporting-NDA-Review-For-NRX-100)*